Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01222182 · ClinicalTrials.gov registry record
Statin Interchange by Pharmacist Collaborative Practice Agreement (CPA)
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 260
- Enrollment target
NCT01222182: Completed study, sponsored by Mayo Clinic.
NCT01222182 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 260 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01222182 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 260 participants
- Enrollment target
Study Summary
A group of \~ 225 patients were switched from atorvastatin to an equivalent statin either by their physicians usual management or by an collaborative pharmacist coordinated process. We will compare the results of pharmacist process to the standard medical practice to find potentially which process is more effective, safer and efficient. We are surveying a total of 35 physicians, 12 using the pharmacist coordinated process and 23 not, comparing their satisfaction of the 2 processes.
Interventions
- DRUG atorvastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2009-09 |
| Est. Completion | 2011-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01222182
The ClinicalTrials.gov registry entry for NCT01222182 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which atorvastatin is the first listed.
NCT01222182 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01222182 about?
NCT01222182 is a clinical study titled "Statin Interchange by Pharmacist Collaborative Practice Agreement (CPA)". A group of \~ 225 patients were switched from atorvastatin to an equivalent statin either by their physicians usual management or by an collaborative pharmacist coordinated process. We will compare the results of pharmacist process to the standard medical practice to find potentially which process i...
What is the current status of trial NCT01222182?
This trial is currently completed. The enrollment target is 260 participants. The study started on 2009-09. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01222182?
The interventions under investigation include: atorvastatin (DRUG).
Who is sponsoring clinical trial NCT01222182?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.